The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate
Urologia Internationalis · 2023 · 107 (4) · 406-412
DOI: 10.1159/000528415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, online erschienen am 31.01.2023. Verfasst von Ran Katz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ziv Medical Center, Azriell Faculty of Medicine, Bar Ilan University, Safed, Israel. Hauptthemen laut MEDLINE: Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Transurethral Resection of Prostate. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The Butterfly Prostatic Retraction device is a novel transurethral implant designed to dilate the prostatic urethra and treat lower urinary tract symptoms. We assessed its safety, efficacy and impact on urinary flow, ejaculation, and quality of life. Materials and Methods: We included 64 men, treated for benign prostate hyperplasia for at least 1 year. All patients had Qmax≤ 13 mL/s and IPSS >12. Insertion of the device was performed via cystoscopy. Follow-up visits were performed at 2 weeks, 1, 3, 6, and 12 months and included uroflowmetry, IPSS, QoL, and sexual function questionnaires. Cystoscopy was performed on 3 and 12 months.
Results
Patients age was 50–83 years. 28 patients completed a 1-year follow-up with an intact device. Mean Qmax improved by 2 mL/s (25%), IPSS median drop was 10 points (40%), and QoL score was 1.5 points (38%). Sexually active patients reported antegrade ejaculation. On cystoscopy, gradual coverage of the devices with urethral mucosa was observed. In 1 patient, the device was repositioned. In 19 patients, the device was removed. 12 patients returned to alpha-blocker therapy and 7 patients underwent TURP. One patient developed a bulbar urethral stricture.
Conclusions
We demonstrated feasibility and good tolerability of the Butterfly device.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Ziv Medical Center, Azriell Faculty of Medicine, Bar Ilan University, Safed, Israel.
- Department of Urology, Shamir Medical Center, Tel Aviv University Faculty of Medicine, Zrifin, Israel.
- Department of Urology, Carmel Medical Center, Technion Faculty of Medicine, Haifa, Israel.
- Department of Urology, Rabin Medical Center, Tel Aviv University Faculty of Medicine, Petach Tikva, Israel.
Zitieren
APA
Katz, R., Ahmed, M. S. A., Safadi, A., Roizman, S., Zisman, A., Kabha, M., Dekel, Y., Baniel, J., & Aharony, S. (2023). The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate. Urologia Internationalis, 107(4), 406-412. https://doi.org/10.1159/000528415
Vancouver
Katz R, Ahmed MSA, Safadi A, Roizman S, Zisman A, Kabha M, et al. The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate. Urologia Internationalis. 2023;107(4):406-412. doi:10.1159/000528415
BibTeX
@article{Katz2023,
author = {Katz, Ran and Ahmed, Muhamad Sabih Abu and Safadi, Ali and Roizman, Shmuel and Zisman, Amnon and Kabha, Maharan and Dekel, Yoram and Baniel, Jack and Aharony, Shachar},
title = {The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate},
journal = {Urologia Internationalis},
year = {2023},
volume = {107},
number = {4},
pages = {406--412},
doi = {10.1159/000528415}
}
EUVIMED